Continuous passive motion (CPM) is a common adjunct to the postoperative therapy program. Use of CPM has been advocated for a variety of diagnoses in hand rehabilitation. This retrospective study compares two groups of patients who underwent digital tenolysis (and/or capsulectomy) and evaluates the use of CPM in their postoperative therapeutic management. Both groups had initial injuries of fractures, tendon lacerations, and/or crush injuries resulting in surgical intervention. After therapeutic rehabilitation, the patients failed to gain satisfactory active ROM and elected to proceed with a secondary surgical procedure. Fifteen patients (19 digits) who used CPM machines in addition to their home exercise program were compared to 21 patients (24 digits) who did not use CPM. Primary outcome comparisons for this study were change in total active motion (TAM) over time (preoperative to discharge from therapy), duration of therapy, and total number of therapy visits. There was no significant difference (F=1.16, p=0.29) in the change in TAM for patients using CPM (39.89 degrees ) compared to those not using CPM treatment (31.83 degrees ). Furthermore, CPM users were seen for significantly more therapy sessions than non-CPM users (25.7 therapy visits compared to 18.54 therapy visits). Rehabilitation lasted approximately the same amount of weeks for both groups (CPM users 10.21 weeks vs. non-CPM users 11.42 weeks).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1197/j.jht.2007.12.004 | DOI Listing |
Alzheimers Dement
December 2024
University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Background: Pharmacoepidemiologic studies assessing drug effectiveness for Alzheimer's disease and related dementias (ADRD) are increasingly popular given the critical need for effective therapies for ADRD. To meet the urgent need for robust dementia ascertainment from real-world data, we aimed to develop a novel algorithm for identifying incident and prevalent dementia in claims.
Method: We developed algorithm candidates by different timing/frequency of dementia diagnosis/treatment to identify dementia from inpatient/outpatient/prescription claims for 6,515 and 3,997 participants from Visits 5 (2011-2013; mean age 75.
Background: The advent of disease-modifying therapies in Alzheimer's disease (AD) necessitates a nuanced understanding of how therapies impact disease processes. Over the past decades, AD clinical trials have primarily relied on classical statistical analysis methodology such as the mixed model for repeated measures (MMRM) to estimate treatment effects. These conventional treatment effect quantifications are given as group differences in clinical outcome measures at a single visit.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
SingHealth Community Hospitals, Singapore, Singapore.
Background: Social robots have been used in other countries for improvement of quality of life for persons with dementia.
Method: LOVOT was introduced as an adjunct to regular therapy sessions (either Physiotherapy or Occupational Therapy) and as an interactive companion during the patient's inpatient stay. The project was carried out over a span of 6 weeks (weekdays) for a maximum of 10-15 mins on an ad-hoc basis.
Alzheimers Dement
December 2024
Alzheimer's Disease Research Center, New York University Langone Health, New York, NY, USA.
Background: Behavioral and psychological symptoms of dementia (BPSD) occur frequently in persons with Alzheimer's disease (PAD). They cause suffering, institutionalization, carepartner distress, depression, burden, and decreased PAD-carepartner quality of life. Brexpiprazole approval advanced the AD treatment armamentarium.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Prevent Alzheimer's Disease 2020, Inc., Rockville, MD, USA.
Background: Disparities in the quality and timeliness of care for Alzheimer's disease (AD) are well documented. This study assessed the impact of demographic characteristics on the diagnosis and management of early AD patients in community-based settings.
Method: This cross-sectional study abstracted medical chart data for patients aged 50-89 years who had newly diagnosed early AD (mild cognitive impairment [MCI] or mild AD) within the past 2 years and a clinic visit within the past 12 months.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!